IN THE NEWS

THE LATEST NEWS

GNS Prominently Featured in BioCentury Cover Story on Use of Machine Learning by Pharma

BioCentury Article Highlights GNS Discoveries on Behalf of The MMRF

GenomeWeb Article Offers Insight on GNS-Celgene Deal and Growing Demand for Causal Modeling

Outsourcing Pharma Puts Spotlight on Power of Causality, Highlights GNS-Celgene Deal Licensing REFS

Xconomy Features Celgene-GNS REFS License, Investment Deal

MS News Today Features GNS ‘Efficacy to Effectiveness’ Solution

GNS REFS™ Causal Machine Learning Platform Featured in GEN (Genetic Engineering & Biotechnology News)

WSJ Pro Venture Capital Coverage of Horizon Investment in GNS Highlights Application of Precision Medicine to Population Health

Modern Healthcare Reports Horizon Investment in GNS, Notes Diverse Stakeholders Among GNS Investors

BioTelemetry, Inc. (NASDAQ:BEAT) Appoints Colin Hill to Board of Directors